- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Androgen insensitive prostate cancer
Total 88286 results
-
Wake Forest University Health SciencesAstellas Pharma Inc; Medivation, Inc.Active, not recruitingProstate Cancer | Prostate AdenocarcinomaUnited States
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingCancer Survivor | Prostate AdenocarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Columbia University; NYU Langone Health; Weill... and other collaboratorsActive, not recruiting
-
Astellas Pharma China, Inc.Active, not recruitingMetastatic Hormone Sensitive Prostate CancerChina
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Cytogen CorporationCompletedProstate CancerUnited States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; Pfizer; Janssen Scientific Affairs, LLCCompletedProstate CancerUnited States
-
IRCCS San RaffaeleCompleted
-
Janssen Research & Development, LLCCompleted
-
Fudan UniversityActive, not recruitingNeoadjuvant Therapy | High-risk Prostate CancerChina
-
Seattle Institute for Biomedical and Clinical ResearchUnited States Department of Defense; University of WashingtonActive, not recruitingMetastatic Prostate Cancer | Androgen Deprivation TherapyUnited States
-
Imperial College LondonCompleted
-
Thomas Jefferson UniversitySuspendedProstate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
DendreonCompletedMetastatic Androgen Independent Prostate CancerUnited States, Canada
-
University of ChicagoCompletedProstate CancerUnited States
-
University of British ColumbiaBritish Columbia Cancer AgencyActive, not recruiting
-
Stanford UniversityNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Millennium Pharmaceuticals, Inc.Active, not recruitingProstate CancerUnited States
-
David VanderWeeleTerminatedCastrate Resistant Prostate CancerUnited States
-
University College, LondonCanadian Cancer Trials GroupCompletedSexual Dysfunction | Prostate Cancer | Gastrointestinal Complications | Urinary ComplicationsUnited Kingdom, Canada
-
Jonsson Comprehensive Cancer CenterViewray Inc.Active, not recruitingPSA Progression | Stage III Prostate Adenocarcinoma AJCC v7 | Stage II Prostate Adenocarcinoma AJCC v7 | PSA Level Greater Than 0.03 | Stage I Prostate Adenocarcinoma AJCC (American Joint Committee on Cancer ) v7United States
-
UNICANCERSanofi; European Organisation for Research and Treatment of Cancer - EORTC; I... and other collaboratorsActive, not recruitingMetastatic Prostate CancerFrance, Ireland, Spain, Switzerland, Belgium, Italy, Romania
-
Memorial Sloan Kettering Cancer CenterCompletedProstate CancerUnited States
-
AmgenTerminatedMetastatic Castration-resistant Prostate CancerUnited States, Sweden, Spain, United Kingdom, Australia, Denmark
-
National Cancer Institute (NCI)Active, not recruitingProstate Cancer | Prostate Neoplasms | Neoplasms, ProstaticUnited States
-
Astellas Pharma IncMedivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration-Resistant Prostate Cancer (CRPC)United States, Moldova, Republic of, South Africa
-
University of WashingtonNational Cancer Institute (NCI)TerminatedMetastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IV Prostate Cancer AJCC v8 | Metastatic Malignant Neoplasm in the Bone | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Prostate Small Cell Neuroendocrine Carcinoma | Castration-Sensitive Prostate CarcinomaUnited States
-
Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator...Active, not recruitingProstate CancerUnited States
-
University of NebraskaAmerican College of Sports MedicineCompletedProstate Cancer | Prostate NeoplasmUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingProstate CancerUnited States, Canada
-
University of FloridaCompletedProstate CancerUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminated
-
National Cancer Institute (NCI)CompletedProstate CancerUnited States
-
M.D. Anderson Cancer CenterBristol-Myers Squibb; Stand Up To Cancer; High Impact Clinical Research Support...Completed
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingProstate Adenocarcinoma | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8United States
-
Medical College of WisconsinCompletedProstate CancerUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Prostate Cancer | Stage IV Prostate CancerUnited States
-
Lawrence FongMerck Sharp & Dohme LLC; Prostate Cancer Foundation; TriSalus Life Sciences,...Active, not recruitingProstatic NeoplasmsUnited States
-
Alessa Therapeutics Inc.CompletedLower Urinary Tract Symptoms | Prostate AdenocarcinomaUnited States, Australia, New Zealand
-
Weill Medical College of Cornell UniversityConvergent Therapeutics, Inc.WithdrawnProstate Cancer MetastaticUnited States
-
NorthShore University HealthSystemNorthwestern University; University of ChicagoCompletedEffect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate CancerProstate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterFerring Pharmaceuticals; University of Michigan; University of Texas Southwestern...Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyActive, not recruitingProstate CancerUnited States, Canada, Israel, Hong Kong, Singapore, Switzerland
-
State University of New York at BuffaloNational Center for Advancing Translational Sciences (NCATS)WithdrawnDiabetes Mellitus, Type 2 | Insulin Resistance | Prostate Cancer | Androgen DeficiencyUnited States
-
University of NebraskaNational Cancer Institute (NCI)WithdrawnRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer
-
NCIC Clinical Trials GroupTerminated
-
NCIC Clinical Trials GroupCompleted
-
Rennes University HospitalCompletedProstate Cancer | Androgen-deprivation TherapyFrance
-
Institut Cancerologie de l'OuestAstellas Pharma Inc; Direction Générale de l'Offre de SoinsActive, not recruitingProstate Cancer | OligometastasisFrance